Article
CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population.
Melanoma research - 1 Jun 2007
Pjanova Dace, Engele Ludmila, Randerson-Moor Juliette A, Harland Mark, Bishop D Timothy, Newton Bishop Julia A, Taylor Claire, Debniak Tadeusz, Lubinski Jan, Kleina Regina, Heisele Olita
Abstract excerpt
Germline mutations of the CDKN2A and CDK4 genes explain a significant proportion of familial melanoma. To date, there have been few published estimations of the prevalence of such mutations in sporadic melanoma patients. In this study, we investigated CDKN2A and CDK4 exon 2 for germline mutations in 125 consecutive cutaneous malignant melanoma patients recruited through the Latvian Oncological Center, using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
